Pancreatic cancer, which mostly creeps in silently, remains a significant global health challenge with increasing incidence and mortality rates worldwide. It is often considered deadly due to its tendency to be diagnosed at a late stage, its aggressive nature, and the lack of effective treatments for advanced cases.
In the middle of this growing concern of pancreatic cancer and a surge in new cases, a new study has uncovered a hidden danger behind a common habit that may put millions at increased risk of this particular type of cancer.
What is it, and how is it affecting millions?
More often than not, common habits that we’re accustomed to – on a daily basis – put us at great risk, without us even realizing it. Smoking is one such habit.
Smoking has long been recognized as a risk factor for pancreatic cancer. Now, new evidence explains how it contributes to tumor growth at a cellular level. Researchers have found that chemicals in cigarette smoke not only spark tumor growth but also suppress the body's immune defenses, creating fertile ground for cancer to flourish.
Smoking: More than just a risk factor
A recent study from the
University of Michigan found that toxins from cigarettes activate specific cells that release a protein called interleukin-22 (IL-22). This protein promotes aggressive tumor growth while simultaneously unleashing a type of immune cell that suppresses the body's anti-tumor response. The result: a double hit for patients, where tumors grow faster, and the immune system is blindsided.
What is pancreatic cancer?
Pancreatic cancer is a disease in which malignant (cancerous) cells form in the tissues of the pancreas. The pancreas is a gland located behind the stomach that plays a crucial role in digestion and blood sugar regulation by producing enzymes and hormones.
While the exact causes are not always clear, risk factors include smoking, family history of pancreatic cancer, long-standing type 2 diabetes, and chronic pancreatitis.
Pancreatic cancer is often difficult to diagnose early because symptoms may be subtle or absent in the early stages.
Rising pancreatic cancer cases: A growing concern
Pancreatic cancer is notoriously lethal. It's often diagnosed late, and five-year survival rates remain under 20% globally. Experts estimate that by 2030, pancreatic cancer may surpass colorectal cancer as the second leading cause of cancer-related deaths in the US, a stark indicator of its growing impact.
Unlike many cancers, where early detection has improved outcomes, pancreatic cancer lacks reliable screening methods for the general public. Most patients are diagnosed only after symptoms appear, usually at an advanced stage when treatment options are limited.
When should you consider screening?
Current guidelines make it clear: screening is not recommended for asymptomatic people at average risk. The U.S. Preventive Services Task Force gives it a "D" rating, meaning the potential harms outweigh the benefits.
However, there are exceptions. Experts now advise proactive screening for high-risk individuals, including those with:
Genetic conditions (e.g., Peutz-Jeghers, familial pancreatic cancer syndromes, BRCA1/2 mutations)A strong family history of pancreatic cancerNew-onset diabetes (especially when accompanied by unexplained weight loss), which may signal early-stage diseaseMajor health centers now recommend annual screening, using MRI or endoscopic ultrasound (EUS), for such high-risk groups, starting at an age tailored to the individual's genetics and family history.
Why screening high-risk groups matters
For people at elevated risk, surveillance can detect tumors at an earlier, more treatable stage. Though testing comes with potential downsides, like increased anxiety, false positives, and invasive follow-ups, the emotional and clinical benefit of early detection often outweighs the risks for these individuals.
Detecting pancreatic cancer in its early stages can significantly improve survival opportunities via surgery and therapy, lifesaving outcomes that are almost impossible when diagnosis comes too late.
While the knowledge has been an age-old piece of information, the connection now is clearer than ever: smoking doesn’t just elevate the risk, it actively boosts pancreatic cancer growth by shutting down the immune system’s defenses. With rising incidence and still-poor survival rates, it's crucial to act now.
While mass screening isn't yet feasible, those at higher risk, either by genetics, family history, or new-onset diabetes, should talk to their doctors about surveillance options like MRI or endoscopic ultrasound. And quitting smoking remains a vital, controllable step everyone can take.
Follow Us On Social Media